FireGate Biotech builds on decades of breakthrough HIV and immunotherapy research. Our work integrates CCR5 blockade, PD-L1 checkpoint modulation, and broadly neutralizing antibodies into next-generation cure strategies.
Publications and reference library coming soon as we advance, we’ll share the science that shapes our mission.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.